Drugs / Antra MUPS®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04679948 | Dec 2020 → Mar 2021 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antra MUPS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04679948 ↗ |
| Route | Oral | “Administered Orally as a Cocktail” NCT04679948 ↗ |